Key terms
About Eli Lilly and Company 0.45% 24-MAY-2028
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
ISIN
CH0323735602
FIGI
BBG00CW37L25
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related bonds
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.